Maximize the therapeutic potential of your cell therapy through efficient and practical scale out. With one G-Rex bioreactor per patient and a small footprint per bioreactor, you can serve a high volume of patients in parallel—potentially treating 10,000 patients a year in 8x less space than conventional bioreactors.
By combining G-Rex bioreactors with Heracell Vios 250i CO2 incubator and efficient cell processing instruments, our platform will process multiple cell therapy products in a day within a small cubic footprint. This allows you to create commercially viable process that can grow with future demand.